Restera
We will not rest until they sleep peacefully
- Employees
- 11–50
- Business Model
- B2B
- Website
- resterasleep.com
About
Restera is a clinical-stage medical technology company developing a first-of-its-kind injectable neurostimulation treatment for obstructive sleep apnea. The company's miniature implant is designed to be placed through a needle in a simple outpatient procedure using ultrasound guidance and precision placement tools. During sleep, the device stimulates neural targets including the Hypoglossal nerve to open the airway and restore breathing. Backed by 6 clinical studies, 68 subjects, 54 patents, and 15 peer-reviewed publications, Restera is advancing a transformative alternative to CPAP therapy.
Summary
Restera is a Biotech company.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/restera"><img src="https://indexed.vc/api/badge/company/restera" alt="Restera on Indexed.vc" width="260" height="76" /></a>